COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 3099: Articles 30981-30990  | Next

In-Silico evidence for two receptors based strategy of SARS-CoV-2
Milanetti, E., Miotto, M., Di Rienzo, L., Monti, M., Gosti, G., Ruocco, G.
10.1101/2020.03.24.006197 — Posted: 2020-03-27
Automatic Identification of SARS Coronavirus using Compression-Complexity Measures
Balasubramanian, K., Nagaraj, N.
10.1101/2020.03.24.006007 — Posted: 2020-03-27 Discussion: Onsite
Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses
Prasanth, K. R., Hirano, M., Fagg, W. S., McAnarney, E., Chan, S., Xie, X., Hage, A., Pietzsch, C., Bukreyev, A., Rajsbaum, R., Shi, P.-Y., Bedford, M., Bradrick, S., Menachery, V. D., Garcia-Blanco, M. A.
10.1101/2020.03.24.005900 — Posted: 2020-03-27
Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein
Liu, H., Lupala, C., Li, X., Lei, J., Chen, H., Qi, J., Su, X.
10.1101/2020.03.24.005561 — Posted: 2020-03-27
Structure-based modeling of SARS-CoV-2 peptide/HLA-A02 antigens
Nerli, S., Sgourakis, N. G.
10.1101/2020.03.23.004176 — Posted: 2020-03-27 Discussion: Onsite
Estimating the ascertainment rate of SARS-CoV-2 infection in Wuhan, China: implications for management of the global outbreak
Lytras, T., Panagiotakopoulos, G., Tsiodras, S.
10.1101/2020.03.24.20042218 — Posted: 2020-03-26
Modes of contact and risk of transmission in COVID-19 among close contacts
Luo, L., Liu, D., Liao, X.-l., Wu, X.-b., Jing, Q.-l., Zheng, J.-z., Liu, F.-h., Yang, S.-g., Bi, B., Li, Z.-h., Liu, J.-p., Song, W.-q., Zhu, W., Wang, Z.-h., Zhang, X.-r., Chen, P.-l., Liu, H.-m., Cheng, X., Cai, M.-c., Huang, Q.-m., Yang, P., Yang, X.-f., Huang, Z.-g., Tang, J.-l., Ma, Y., Mao, C.
10.1101/2020.03.24.20042606 — Posted: 2020-03-26 Discussion: Onsite
Viral Kinetics and Antibody Responses in Patients with COVID-19
Tan, W., Lu, Y., Zhang, J., Wang, J., Dan, Y., Tan, Z., He, X., Qian, C., Sun, Q., Hu, Q., Liu, H., Ye, S., Xiang, X., Zhou, Y., Zhang, W., Guo, Y., Wang, X.-H., He, W., Wan, X., Sun, F., Wei, Q., Chen, C., Pan, G., Xia, J., Mao, Q., Chen, Y., Deng, G.
10.1101/2020.03.24.20042382 — Posted: 2020-03-26 Discussion: Onsite | Offsite
COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis
Nasiri, M. J., Haddadi, S., Tahvildari, A., Farsi, Y., Arbabi, M., Hasanzadeh, S., Jamshidi, P., Murthi, M., Mirsaeidi, M.
10.1101/2020.03.24.20042903 — Posted: 2020-03-26
Human leukocyte antigen susceptibility map for SARS-CoV-2
Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., Thompson, R. F.
10.1101/2020.03.22.20040600 — Posted: 2020-03-26 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).